06
— Weight Loss
GLP-1 weight loss,
properly supervised.
Semaglutide and tirzepatide deliver real, sustained weight loss when prescribed correctly. Most GLP-1 telehealth providers skip the labs, skip the titration, and skip the follow-up. We don't. Comprehensive bloodwork before you start, careful dose titration, and a licensed provider following your progress at every step.
Starting
$249 / mo
Cadence
Weekly injection
Monitoring
Monthly first 90 days
Onset
4–8 weeks
— Who it's for
Adults seeking sustained weight loss with medical supervision.
- IndicationAdults with BMI ≥ 30, or BMI ≥ 27 with comorbidities.
- IndicationPatients who've tried lifestyle interventions without sufficient results.
- IndicationPatients seeking a sustained approach paired with metabolic optimization, not a crash protocol.
- IndicationPatients ready to maintain monthly follow-up during titration.
— Not for
A short list of when GLP-1s aren't right.
- SkipPersonal or family history of medullary thyroid carcinoma or MEN-2.
- SkipActive pancreatitis or severe GI conditions.
- SkipPregnancy or active attempt to conceive.
- SkipPatients with BMI < 27 or seeking cosmetic weight loss only.
— From the clinic
The mistake most GLP-1 telehealth practices make is starting patients at high doses to chase the scale. We titrate slowly, monitor labs, and treat side effects when they appear — that's how patients actually stay on the protocol long enough for it to work.
— How it works
Weekly injection, slow titration, real follow-up.
Semaglutide (generic Ozempic / Wegovy) and tirzepatide (generic Mounjaro / Zepbound) are GLP-1 receptor agonists — they reduce appetite, slow gastric emptying, and improve insulin sensitivity. We start at low doses and increase only as tolerated, with monthly check-ins for the first 90 days.
- ProtocolSemaglutide 0.25 mg → titrated weekly. Tirzepatide 2.5 mg → titrated weekly.
- CadenceOnce-weekly subcutaneous injection, self-administered at home.
- BloodworkComprehensive labs before starting, repeated at 3 and 6 months.
- ProviderMonthly follow-up for the first 90 days, then quarterly.
— What to expect
The first six months.
- Week 1–4Mild appetite reduction. Possible nausea or GI changes — usually manageable.
- Week 4–12Steady weight loss begins. Cravings noticeably reduce. Energy stabilizes.
- Month 3–6Most patients see 10–15% body-weight reduction. Dose may plateau or continue titrating.
- Month 6+Maintenance phase. Some patients reduce dose, some continue. Provider guides the long-term plan.
— Safety & monitoring
What we watch — and why.
Our standard panel covers comprehensive metabolic, lipids, A1c, thyroid, liver, kidney function, and inflammatory markers. We require labs before prescribing and at 3 and 6 months. Side effects are common during titration — nausea, GI changes, fatigue — and almost always resolve with dose adjustment or anti-nausea support.
— What members say
Sustained loss without the white-knuckle hunger.
Down 38 pounds over six months. The titration plan was patient — small doses, give it time. My A1c is back in the normal range for the first time in a decade.
T.W.
Tirzepatide · Performance tier · Member since 2024
I was on semaglutide from a different clinic and quit after six weeks because of nausea. Stria's provider adjusted my dose, gave me anti-nausea support, and I'm still on the protocol nine months later.
M.B.
Semaglutide · Foundation · Member since 2024
The labs surprised me — cholesterol, blood sugar, inflammation markers all improved alongside the weight loss. This is the first weight protocol I've stayed on past month three.
R.L.
Semaglutide · Complete · Member since 2024
— Disclaimer
The honest fine print.
Semaglutide and tirzepatide are FDA-approved for chronic weight management in qualifying adults. Compounded versions are dispensed by 503A pharmacy partners when commercial supply is constrained. Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain. Rare but serious side effects include pancreatitis, gallbladder issues, and acute kidney injury. Requires ongoing medical supervision. Not approved for cosmetic weight loss in adults with BMI < 27 without comorbidities.
— Next step
Start with the assessment.
15 minutes. Free to take. You don’t pay until a licensed provider approves your protocol.